Anavex Life Sciences Corp. (LON:0HFR)
9.36
-0.31 (-3.18%)
At close: Aug 19, 2025
Anavex Life Sciences Statistics
Total Valuation
LON:0HFR has a market cap or net worth of GBP 600.46 million. The enterprise value is 525.54 million.
Market Cap | 600.46M |
Enterprise Value | 525.54M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 85.89M |
Shares Outstanding | n/a |
Shares Change (YoY) | +2.72% |
Shares Change (QoQ) | +0.36% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 83.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 5.58 |
PS Ratio | n/a |
PB Ratio | 9.04 |
P/TBV Ratio | 9.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -14.95 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.93
Current Ratio | 8.93 |
Quick Ratio | 8.89 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.64% and return on invested capital (ROIC) is -30.30%.
Return on Equity (ROE) | -43.64% |
Return on Assets (ROA) | -27.41% |
Return on Invested Capital (ROIC) | -30.30% |
Return on Capital Employed (ROCE) | -58.82% |
Revenue Per Employee | n/a |
Profits Per Employee | -837,126 |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.75% in the last 52 weeks. The beta is 0.80, so LON:0HFR's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | +53.75% |
50-Day Moving Average | 10.34 |
200-Day Moving Average | 9.29 |
Relative Strength Index (RSI) | 35.53 |
Average Volume (20 Days) | 5,051 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 23.44 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.05M |
Pretax Income | -35.16M |
Net Income | -35.16M |
EBITDA | n/a |
EBIT | -39.05M |
Earnings Per Share (EPS) | -0.41 |
Balance Sheet
The company has 73.84 million in cash and n/a in debt, giving a net cash position of 73.84 million.
Cash & Cash Equivalents | 73.84M |
Total Debt | n/a |
Net Cash | 73.84M |
Net Cash Per Share | n/a |
Equity (Book Value) | 66.39M |
Book Value Per Share | 0.78 |
Working Capital | 66.39M |
Cash Flow
Operating Cash Flow | -27.08M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LON:0HFR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.72% |
Shareholder Yield | n/a |
Earnings Yield | -5.86% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |